메뉴 건너뛰기




Volumn 144, Issue 5, 2013, Pages 933-944

Accuracy of risk scores for patients with chronic hepatitis B receiving entecavir treatment

Author keywords

Cirrhosis; Entecavir; Hepatocellular Carcinoma; Risk Scores

Indexed keywords

ENTECAVIR;

EID: 84876496527     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.02.002     Document Type: Article
Times cited : (148)

References (28)
  • 1
    • 33646337650 scopus 로고    scopus 로고
    • Hepatocellular carcinoma and hepatitis B virus
    • H.L. Chan, J.J. Sung Hepatocellular carcinoma and hepatitis B virus Semin Liver Dis 26 2006 153 161
    • (2006) Semin Liver Dis , vol.26 , pp. 153-161
    • Chan, H.L.1    Sung, J.J.2
  • 2
    • 38349094747 scopus 로고    scopus 로고
    • High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma
    • H.L. Chan, C.H. Tse, F. Mo High viral load and hepatitis B virus subgenotype ce are associated with increased risk of hepatocellular carcinoma J Clin Oncol 26 2008 177 182
    • (2008) J Clin Oncol , vol.26 , pp. 177-182
    • Chan, H.L.1    Tse, C.H.2    Mo, F.3
  • 3
    • 29944436855 scopus 로고    scopus 로고
    • Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
    • C.J. Chen, H.I. Yang, J. Su Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level JAMA 295 2006 65 73
    • (2006) JAMA , vol.295 , pp. 65-73
    • Chen, C.J.1    Yang, H.I.2    Su, J.3
  • 4
    • 77950500095 scopus 로고    scopus 로고
    • Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers
    • V.W. Wong, S.L. Chan, F. Mo Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers J Clin Oncol 28 2010 1660 1665
    • (2010) J Clin Oncol , vol.28 , pp. 1660-1665
    • Wong, V.W.1    Chan, S.L.2    Mo, F.3
  • 5
    • 77952514489 scopus 로고    scopus 로고
    • Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    • H.I. Yang, M. Sherman, J. Su Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection J Clin Oncol 28 2010 2437 2444
    • (2010) J Clin Oncol , vol.28 , pp. 2437-2444
    • Yang, H.I.1    Sherman, M.2    Su, J.3
  • 6
    • 84984550778 scopus 로고    scopus 로고
    • Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): Development and validation of a predictive score
    • H.I. Yang, M.F. Yuen, H.L. Chan Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score Lancet Oncol 12 2011 568 574
    • (2011) Lancet Oncol , vol.12 , pp. 568-574
    • Yang, H.I.1    Yuen, M.F.2    Chan, H.L.3
  • 7
    • 56949094767 scopus 로고    scopus 로고
    • Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B
    • M.F. Yuen, Y. Tanaka, D.Y. Fong Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B J Hepatol 50 2009 80 88
    • (2009) J Hepatol , vol.50 , pp. 80-88
    • Yuen, M.F.1    Tanaka, Y.2    Fong, D.Y.3
  • 8
    • 53549107488 scopus 로고    scopus 로고
    • Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma
    • J.J. Sung, K.K. Tsoi, V.W. Wong Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma Aliment Pharmacol Ther 28 2008 1067 1077
    • (2008) Aliment Pharmacol Ther , vol.28 , pp. 1067-1077
    • Sung, J.J.1    Tsoi, K.K.2    Wong, V.W.3
  • 9
    • 84860529958 scopus 로고    scopus 로고
    • Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years
    • G.L. Wong, V.W. Wong, H.Y. Chan Undetectable HBV DNA at month 12 of entecavir treatment predicts maintained viral suppression and HBeAg-seroconversion in chronic hepatitis B patients at 3 years Aliment Pharmacol Ther 35 2012 1326 1335
    • (2012) Aliment Pharmacol Ther , vol.35 , pp. 1326-1335
    • Wong, G.L.1    Wong, V.W.2    Chan, H.Y.3
  • 10
    • 75449107726 scopus 로고    scopus 로고
    • Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B
    • T.T. Chang, C.L. Lai, S. Kew Yoon Entecavir treatment for up to 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B Hepatology 51 2010 422 430
    • (2010) Hepatology , vol.51 , pp. 422-430
    • Chang, T.T.1    Lai, C.L.2    Kew Yoon, S.3
  • 11
    • 84862664371 scopus 로고    scopus 로고
    • EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection
    • European Association For The Study Of The Liver
    • European Association For The Study Of The Liver EASL Clinical Practice Guidelines: Management of chronic hepatitis B virus infection J Hepatol 57 2012 167 185
    • (2012) J Hepatol , vol.57 , pp. 167-185
  • 12
    • 51049107683 scopus 로고    scopus 로고
    • Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2008 update
    • Y.F. Liaw, N. Leung, J.H. Kao Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update Hepatol Int 2 2008 263 283
    • (2008) Hepatol Int , vol.2 , pp. 263-283
    • Liaw, Y.F.1    Leung, N.2    Kao, J.H.3
  • 13
    • 70349240414 scopus 로고    scopus 로고
    • Chronic hepatitis B: Update 2009
    • A.S. Lok, B.J. McMahon Chronic hepatitis B: update 2009 Hepatology 50 2009 661 662
    • (2009) Hepatology , vol.50 , pp. 661-662
    • Lok, A.S.1    McMahon, B.J.2
  • 14
    • 55349135866 scopus 로고    scopus 로고
    • Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis
    • E. Schiff, H. Simsek, W.M. Lee Efficacy and safety of entecavir in patients with chronic hepatitis B and advanced hepatic fibrosis or cirrhosis Am J Gastroenterol 103 2008 2776 2783
    • (2008) Am J Gastroenterol , vol.103 , pp. 2776-2783
    • Schiff, E.1    Simsek, H.2    Lee, W.M.3
  • 15
    • 75349107764 scopus 로고    scopus 로고
    • Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis
    • J.H. Shim, H.C. Lee, K.M. Kim Efficacy of entecavir in treatment-naive patients with hepatitis B virus-related decompensated cirrhosis J Hepatol 52 2010 176 182
    • (2010) J Hepatol , vol.52 , pp. 176-182
    • Shim, J.H.1    Lee, H.C.2    Kim, K.M.3
  • 16
    • 84875870984 scopus 로고    scopus 로고
    • Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis
    • [Epub ahead of print]
    • R. Zoutendijk, J.G. Reijnders, F. Zoulim Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis Gut 2012 Apr 5 [Epub ahead of print]
    • (2012) Gut
    • Zoutendijk, R.1    Reijnders, J.G.2    Zoulim, F.3
  • 17
    • 80052390410 scopus 로고    scopus 로고
    • Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma
    • Y.J. Jin, J.H. Shim, H.C. Lee Suppressive effects of entecavir on hepatitis B virus and hepatocellular carcinoma J Gastroenterol Hepatol 26 2011 1380 1388
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 1380-1388
    • Jin, Y.J.1    Shim, J.H.2    Lee, H.C.3
  • 18
    • 0036779279 scopus 로고    scopus 로고
    • Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation
    • H.L. Chan, A.K. Chui, W.Y. Lau Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation J Med Virol 68 2002 182 187
    • (2002) J Med Virol , vol.68 , pp. 182-187
    • Chan, H.L.1    Chui, A.K.2    Lau, W.Y.3
  • 19
    • 80054724912 scopus 로고    scopus 로고
    • Hepatitis B surface antigen quantification: Why and how to use it in 2011 - A core group report
    • H.L. Chan, A. Thompson, M. Martinot-Peignoux Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report J Hepatol 55 2011 1121 1131
    • (2011) J Hepatol , vol.55 , pp. 1121-1131
    • Chan, H.L.1    Thompson, A.2    Martinot-Peignoux, M.3
  • 20
    • 79952231921 scopus 로고    scopus 로고
    • Management of hepatocellular carcinoma: An update
    • American Association for the Study of Liver D
    • J. Bruix, M. Sherman American Association for the Study of Liver D Management of hepatocellular carcinoma: an update Hepatology 53 2011 1020 1022
    • (2011) Hepatology , vol.53 , pp. 1020-1022
    • Bruix, J.1    Sherman, M.2
  • 21
    • 0033936550 scopus 로고    scopus 로고
    • Time-dependent ROC curves for censored survival data and a diagnostic marker
    • P.J. Heagerty, T. Lumley, M.S. Pepe Time-dependent ROC curves for censored survival data and a diagnostic marker Biometrics 56 2000 337 344
    • (2000) Biometrics , vol.56 , pp. 337-344
    • Heagerty, P.J.1    Lumley, T.2    Pepe, M.S.3
  • 22
    • 84871650559 scopus 로고    scopus 로고
    • Who will have the best response to entecavir?
    • G.L. Wong Who will have the best response to entecavir? J Gastroenterol Hepatol 28 2013 5 7
    • (2013) J Gastroenterol Hepatol , vol.28 , pp. 5-7
    • Wong, G.L.1
  • 23
    • 84860173190 scopus 로고    scopus 로고
    • Identifying hepatitis B carriers at low risk for hepatocellular carcinoma
    • H.L. Chan Identifying hepatitis B carriers at low risk for hepatocellular carcinoma Gastroenterology 142 2012 1057 1060
    • (2012) Gastroenterology , vol.142 , pp. 1057-1060
    • Chan, H.L.1
  • 24
    • 77951227166 scopus 로고    scopus 로고
    • Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B
    • G.L. Wong, V.W. Wong, P.C. Choi Development of a non-invasive algorithm with transient elastography (Fibroscan) and serum test formula for advanced liver fibrosis in chronic hepatitis B Aliment Pharmacol Ther 31 2010 1095 1103
    • (2010) Aliment Pharmacol Ther , vol.31 , pp. 1095-1103
    • Wong, G.L.1    Wong, V.W.2    Choi, P.C.3
  • 25
    • 84983726112 scopus 로고    scopus 로고
    • High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load
    • e3; quiz e13-14
    • T.C. Tseng, C.J. Liu, H.C. Yang High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load Gastroenterology 142 2012 1140 1149 e3; quiz e13-14
    • (2012) Gastroenterology , vol.142 , pp. 1140-1149
    • Tseng, T.C.1    Liu, C.J.2    Yang, H.C.3
  • 26
    • 37449030467 scopus 로고    scopus 로고
    • Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis
    • G.L. Wong, V.W. Wong, G.M. Tan Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitis Liver Int 28 2008 79 87
    • (2008) Liver Int , vol.28 , pp. 79-87
    • Wong, G.L.1    Wong, V.W.2    Tan, G.M.3
  • 27
    • 84859308589 scopus 로고    scopus 로고
    • Prevention of hepatocellular carcinoma: A concise review of contemporary issues
    • V.W. Wong, H.L. Chan Prevention of hepatocellular carcinoma: a concise review of contemporary issues Ann Hepatol 11 2012 284 293
    • (2012) Ann Hepatol , vol.11 , pp. 284-293
    • Wong, V.W.1    Chan, H.L.2
  • 28
    • 84865490229 scopus 로고    scopus 로고
    • Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naive patients with chronic hepatitis B
    • e1
    • A.S. Lok, H. Trinh, G. Carosi Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos(t)ide-naive patients with chronic hepatitis B Gastroenterology 143 2012 619 628 e1
    • (2012) Gastroenterology , vol.143 , pp. 619-628
    • Lok, A.S.1    Trinh, H.2    Carosi, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.